Literature DB >> 22868864

Epilepsy: Update to guidelines on treatment of infantile spasms.

Raili Riikonen.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22868864     DOI： 10.1038/nrneurol.2012.157

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.

Authors:  Katrina Darke; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Andrew L Lux; Richard W Newton; Finbar J K O'Callaghan; Christopher M Verity; John P Osborne
Journal:  Arch Dis Child       Date:  2010-05       Impact factor: 3.791

2.  The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.

Authors:  Andrew L Lux; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Richard W Newton; Finbar J K O'Callaghan; Christopher M Verity; John P Osborne
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

3.  Electroretinographic (ERG) responses in pediatric patients using vigabatrin.

Authors:  Anne Moskowitz; Ronald M Hansen; Susan E Eklund; Anne B Fulton
Journal:  Doc Ophthalmol       Date:  2012-03-20       Impact factor: 2.379

4.  Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  C Y Go; M T Mackay; S K Weiss; D Stephens; T Adams-Webber; S Ashwal; O C Snead
Journal:  Neurology       Date:  2012-06-12       Impact factor: 9.910

Review 5.  Long-term outcome of patients with West syndrome.

Authors:  R Riikonen
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

6.  Insulin-like growth factor-1 is associated with cognitive outcome in infantile spasms.

Authors:  Raili S Riikonen; Jarmo Jääskeläinen; Ursula Turpeinen
Journal:  Epilepsia       Date:  2010-02-12       Impact factor: 5.864

7.  Antiepileptic drugs and apoptosis in the developing brain.

Authors:  Petra Bittigau; Marco Sifringer; Chrysanthy Ikonomidou
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

Review 8.  Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Authors:  M T Mackay; S K Weiss; T Adams-Webber; S Ashwal; D Stephens; K Ballaban-Gill; T Z Baram; M Duchowny; D Hirtz; J M Pellock; W D Shields; S Shinnar; E Wyllie; O C Snead
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910
  8 in total
  4 in total

Review 1.  Recent advances in the pharmacotherapy of infantile spasms.

Authors:  Raili Riikonen
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

2.  Stability and Pharmacological Effects of Gene-Recombinant Wild Type and Mutant Human Adrenocorticotropic Hormone.

Authors:  Yonglin Huang; Yechun Pei; Huai Guan; Shuangshuang Wei; Hao Wu; Yuan Zhou; Jinli Pei; Lintao Chen; Yuerong Wang; Yibo Chen; Qian Han; Daming Wang; Dayong Wang
Journal:  Pharm Res       Date:  2017-01-26       Impact factor: 4.200

3.  Infantile Spasms: Clinical profile and treatment outcomes.

Authors:  Shazia Kulsoom; Shahnaz H Ibrahim; Sidra Kaleem Jafri; Khemchand N Moorani; Misbah Anjum
Journal:  Pak J Med Sci       Date:  2018 Nov-Dec       Impact factor: 1.088

4.  Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome.

Authors:  Stéphane Auvin; Blandine Dozières-Puyravel; Andreja Avbersek; David Sciberras; Jo Collier; Karine Leclercq; Pavel Mares; Rafal M Kaminski; Pierandrea Muglia
Journal:  Ann Clin Transl Neurol       Date:  2020-02-27       Impact factor: 4.511
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.